10x Genomics, Inc.
US ˙ NasdaqGS ˙ US88025U1097

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Sridhar Kosaraju. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Sridhar Kosaraju har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TXG / 10x Genomics, Inc. Director 56.449
US:NVRO / Nevro Corp. Director 0
US:PEN / Penumbra, Inc. President 155.351
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Sridhar Kosaraju. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb TXG / 10x Genomics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TXG / 10x Genomics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TXG / 10x Genomics, Inc. Insider Trades
Insidersalg TXG / 10x Genomics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TXG / 10x Genomics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TXG / 10x Genomics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Sridhar Kosaraju som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-05 2025-06-03 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 15.357 56.449 37,37
2025-04-03 2025-04-03 4 NVRO NEVRO CORP
Common Stock
D - Sale to Issuer -46.575 0 -100,00
2025-01-02 2024-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 4.233 46.575 10,00
2024-10-02 2024-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 2.817 42.342 7,13
2024-07-02 2024-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 1.870 39.525 4,97
2024-06-13 2024-06-11 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 8.649 41.092 26,66
2024-05-28 2024-05-23 4 NVRO NEVRO CORP
Common Stock
A - Award 19.169 37.655 103,69
2024-04-02 2024-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 1.090 18.486 6,27
2024-01-03 2023-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 731 17.396 4,39
2023-10-03 2023-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 819 16.665 5,17
2023-07-05 2023-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 619 15.846 4,07
2023-06-16 2023-06-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 1.865 32.443 6,10
2023-05-30 2023-05-25 4 NVRO NEVRO CORP
Common Stock
A - Award 6.754 15.227 79,71
2023-04-04 2023-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 435 8.473 5,41
2023-01-04 2022-12-30 4 NVRO NEVRO CORP
Common Stock
A - Award 397 8.038 5,20
2022-10-04 2022-09-30 4 NVRO NEVRO CORP
Common Stock
A - Award 337 7.641 4,61
2022-09-16 2022-09-14 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 10.000 30.578 48,60 11,48 114.800 351.035
2022-07-05 2022-06-30 4 NVRO NEVRO CORP
Common Stock
A - Award 331 7.304 4,75
2022-06-17 2022-06-15 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 2.120 20.578 11,49
2022-05-27 2022-05-26 4 NVRO NEVRO CORP
Common Stock
A - Award 4.155 6.973 147,44
2022-05-17 2022-05-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -15.000 94.167 -13,74
2022-05-17 2022-05-16 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 15.000 18.458 433,78 11,48 172.200 211.898
2022-04-04 2022-03-31 4 NVRO NEVRO CORP
Common Stock
A - Award 190 2.818 7,23
2022-01-04 2021-12-30 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.500 3.000 -33,33 150,38 -225.569 451.138
2022-01-04 2021-12-31 4 NVRO NEVRO CORP
Common Stock
A - Award 169 2.628 6,87
2021-11-29 2021-11-24 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.500 4.500 -25,00 150,06 -225.084 675.253
2021-10-27 2021-10-25 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 6.000 -4,76 168,68 -50.604 1.012.080
2021-10-27 2021-10-25 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 6.300 -1,56 167,63 -16.763 1.056.069
2021-10-27 2021-10-25 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 6.400 -5,88 166,60 -66.641 1.066.261
2021-10-27 2021-10-25 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 6.800 -8,11 165,14 -99.084 1.122.957
2021-10-27 2021-10-25 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 7.400 -1,33 163,85 -16.385 1.212.490
2021-09-24 2021-09-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.100 7.500 -12,79 159,52 -175.477 1.196.434
2021-09-24 2021-09-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 8.600 -4,44 157,71 -63.085 1.356.328
2021-09-02 2021-08-31 4 NVRO NEVRO CORP
Common Stock
A - Award 2.459 2.459
2021-08-25 2021-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 9.000 -1,10 164,05 -16.405 1.476.450
2021-08-25 2021-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 9.100 -6,19 163,25 -97.948 1.485.552
2021-08-25 2021-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 9.700 -4,90 162,27 -81.135 1.574.019
2021-08-25 2021-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 10.200 -0,97 160,56 -16.056 1.637.712
2021-08-25 2021-08-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 10.300 -1,90 157,72 -31.543 1.624.464
2021-07-26 2021-07-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -241 10.500 -2,24 185,96 -44.815 1.952.529
2021-07-26 2021-07-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 10.741 -3,59 184,43 -73.771 1.980.934
2021-07-26 2021-07-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 11.141 -3,47 183,07 -73.230 2.039.636
2021-07-26 2021-07-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -459 11.541 -3,82 182,32 -83.684 2.104.141
2021-06-25 2021-06-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 12.000 -3,23 201,74 -80.695 2.420.852
2021-06-25 2021-06-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -500 12.400 -3,88 200,03 -100.016 2.480.399
2021-06-25 2021-06-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 12.900 -3,01 199,40 -79.760 2.572.260
2021-06-25 2021-06-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 13.300 -1,48 197,26 -39.452 2.623.558
2021-06-15 2021-06-11 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 1.563 1.563
2021-06-15 2021-06-11 4 TXG 10x Genomics, Inc.
Class A Common Stock
A - Award 625 3.458 22,06
2021-05-26 2021-05-24 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 13.500 -0,74 163,04 -16.304 2.201.040
2021-05-26 2021-05-24 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 13.600 -2,16 162,05 -48.616 2.203.925
2021-05-26 2021-05-24 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -700 13.900 -4,79 161,15 -112.805 2.239.995
2021-05-26 2021-05-24 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 14.600 -2,67 160,05 -64.021 2.336.749
2021-04-27 2021-04-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 15.000 -0,66 194,74 -19.474 2.921.100
2021-04-27 2021-04-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -600 15.100 -3,82 193,98 -116.386 2.929.038
2021-04-27 2021-04-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -400 15.700 -2,48 193,11 -77.246 3.031.887
2021-04-27 2021-04-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -300 16.100 -1,83 191,71 -57.513 3.086.531
2021-04-27 2021-04-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 16.400 -0,61 190,05 -19.005 3.116.820
2021-03-25 2021-03-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -200 16.500 -1,20 178,06 -35.613 2.938.072
2021-03-25 2021-03-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -100 16.700 -0,60 175,71 -17.571 2.934.357
2021-03-25 2021-03-23 4 TXG 10x Genomics, Inc.
Class A Common Stock
S - Sale X -1.200 16.800 -6,67 173,96 -208.755 2.922.570
2021-03-25 2021-01-25 4 TXG 10x Genomics, Inc.
Class A Common Stock
G - Gift 7.167 18.000 66,16
2021-03-25 2021-01-25 4 TXG 10x Genomics, Inc.
Class A Common Stock
G - Gift -7.167 2.833 -71,67
2020-06-17 2020-06-15 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
A - Award 4.432 4.432
2020-06-01 2020-05-29 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
M - Exercise -10.000 109.167 -8,39
2020-06-01 2020-05-29 4 TXG 10x Genomics, Inc.
Class A Common Stock
M - Exercise 10.000 10.000 11,48 114.800 114.800
2020-04-17 2020-04-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -700 155.351 -0,45 171,46 -120.022 26.636.482
2020-04-17 2020-04-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -383 156.051 -0,24 170,30 -65.225 26.575.485
2020-04-17 2020-04-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -600 156.434 -0,38 169,40 -101.640 26.499.920
2020-04-17 2020-04-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -217 157.034 -0,14 168,41 -36.545 26.446.096
2020-04-17 2020-04-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -300 157.251 -0,19 167,26 -50.178 26.301.802
2020-04-17 2020-04-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 157.551 -0,06 166,16 -16.616 26.178.674
2020-04-17 2020-04-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 157.651 -0,13 164,89 -32.978 25.995.073
2020-03-18 2020-03-16 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.800 157.851 -1,13 155,46 -279.828 24.539.516
2020-03-18 2020-03-16 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 159.651 -0,06 153,07 -15.307 24.437.779
2020-03-18 2020-03-16 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 159.751 -0,13 152,47 -30.494 24.357.235
2020-03-18 2020-03-16 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 159.951 -0,12 151,36 -30.272 24.210.183
2020-03-18 2020-03-16 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 160.151 -0,12 150,00 -30.000 24.022.650
2020-02-20 2020-02-18 4 PEN Penumbra Inc
Common Stock
S - Sale X -300 160.351 -0,19 191,51 -57.453 30.708.820
2020-02-20 2020-02-18 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.700 160.651 -1,05 190,79 -324.343 30.650.604
2020-02-20 2020-02-18 4 PEN Penumbra Inc
Common Stock
S - Sale X -500 162.351 -0,31 189,93 -94.965 30.835.325
2020-02-14 2019-08-26 5 PEN Penumbra Inc
Common Stock
G - Gift -1.000 165.351 -0,60
2020-02-03 2020-01-30 4 PEN Penumbra Inc
Common Stock
S - Sale X -500 163.851 -0,30 178,08 -89.040 29.178.586
2020-02-03 2020-01-30 4 PEN Penumbra Inc
Common Stock
S - Sale X -300 164.351 -0,18 177,40 -53.220 29.155.867
2020-02-03 2020-01-30 4 PEN Penumbra Inc
Common Stock
S - Sale X -500 164.651 -0,30 176,01 -88.005 28.980.223
2020-02-03 2020-01-30 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.200 165.151 -0,72 175,09 -210.108 28.916.289
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other 119.167 119.167
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Stock Option (right to buy)
J - Other -119.167 0 -100,00
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Class A Common Stock
J - Other 10.833 10.833
2019-09-16 2019-09-16 4 TXG 10x Genomics, Inc.
Class B Common Stock
J - Other -10.833 0 -100,00
2019-09-11 3 TXG 10x Genomics, Inc.
Class B Common Stock
21.666
2019-09-11 3 TXG 10x Genomics, Inc.
Class B Common Stock
21.666
2019-09-11 3 TXG 10x Genomics, Inc.
Class B Common Stock
21.666
2019-08-02 2019-08-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 166.351 -0,06 172,31 -17.231 28.663.941
2019-08-02 2019-08-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -600 166.451 -0,36 171,65 -102.990 28.571.314
2019-08-02 2019-08-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.505 167.051 -0,89 170,66 -256.843 28.508.924
2019-08-02 2019-08-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -400 168.556 -0,24 169,60 -67.840 28.587.098
2019-08-02 2019-08-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -740 168.956 -0,44 168,56 -124.734 28.479.223
2019-08-02 2019-08-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.049 169.696 -0,61 167,89 -176.117 28.490.261
2019-08-02 2019-08-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -606 170.745 -0,35 166,78 -101.069 28.476.851
2019-07-03 2019-07-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 171.351 -0,06 162,12 -16.212 27.779.424
2019-07-03 2019-07-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -132 171.451 -0,08 161,14 -21.270 27.627.614
2019-07-03 2019-07-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -3.023 171.583 -1,73 160,08 -483.922 27.467.007
2019-07-03 2019-07-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.745 174.606 -0,99 159,54 -278.397 27.856.641
2019-06-05 2019-06-03 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 176.351 -0,11 144,35 -28.870 25.456.267
2019-06-05 2019-06-03 4 PEN Penumbra Inc
Common Stock
S - Sale X -2.449 176.551 -1,37 143,77 -352.093 25.382.737
2019-06-05 2019-06-03 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.089 179.000 -0,60 142,88 -155.596 25.575.520
2019-06-05 2019-06-03 4 PEN Penumbra Inc
Common Stock
S - Sale X -362 180.089 -0,20 141,56 -51.245 25.493.399
2019-06-05 2019-06-03 4 PEN Penumbra Inc
Common Stock
S - Sale X -900 180.451 -0,50 140,73 -126.657 25.394.869
2019-06-05 2019-05-17 4 PEN Penumbra Inc
Common Stock
G - Gift -1.000 181.351 -0,55
2019-05-03 2019-05-02 4 PEN Penumbra Inc
Common Stock
S - Sale X -4.449 182.351 -2,38 130,04 -578.548 23.712.924
2019-05-03 2019-05-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -8 186.800 0,00 135,52 -1.084 25.315.136
2019-05-03 2019-05-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 186.808 -0,05 134,88 -13.488 25.196.663
2019-05-03 2019-05-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 186.908 -0,11 132,30 -26.460 24.727.928
2019-05-03 2019-05-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -243 187.108 -0,13 130,23 -31.646 24.367.075
2019-04-30 2019-04-29 4 PEN Penumbra Inc
Common Stock
F - Taxes -79.615 71.601 -52,65
2019-04-03 2019-04-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 115.750 -0,09 148,43 -14.843 17.180.772
2019-04-03 2019-04-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 115.850 -0,09 147,50 -14.750 17.087.875
2019-04-03 2019-04-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 115.950 -0,17 146,80 -29.360 17.021.460
2019-04-03 2019-04-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -617 116.150 -0,53 144,67 -89.261 16.803.420
2019-04-03 2019-04-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -800 116.767 -0,68 144,03 -115.224 16.817.951
2019-04-03 2019-04-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -2.183 117.567 -1,82 142,91 -311.973 16.801.500
2019-04-03 2019-04-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.000 119.750 -0,83 141,84 -141.840 16.985.340
2019-03-13 2019-03-11 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.200 120.750 -0,98 140,88 -169.056 17.011.260
2019-03-13 2019-03-11 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.600 121.950 -1,30 140,35 -224.560 17.115.682
2019-03-13 2019-03-11 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.400 123.550 -1,12 139,26 -194.964 17.205.573
2019-03-13 2019-03-11 4 PEN Penumbra Inc
Common Stock
S - Sale X -800 124.950 -0,64 138,30 -110.640 17.280.585
2018-05-01 2018-04-28 4 PEN Penumbra Inc
Common Stock
F - Taxes -79.612 222.819 -26,32 126,45 -10.066.937 28.175.463
2018-02-14 2017-11-22 5 PEN Penumbra Inc
Common Stock
G - Gift -1.000 54.147 -1,81
2017-11-29 2017-11-28 4 PEN Penumbra Inc
Common Stock
S - Sale X -504 55.147 -0,91 105,13 -52.986 5.797.604
2017-11-29 2017-11-28 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 55.651 -0,36 104,00 -20.800 5.787.704
2017-11-29 2017-11-28 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.797 55.851 -3,12 103,20 -185.450 5.763.823
2017-11-29 2017-11-27 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.300 57.648 -2,21 104,83 -136.279 6.043.240
2017-11-29 2017-11-27 4 PEN Penumbra Inc
Common Stock
S - Sale X -2.225 58.948 -3,64 103,45 -230.176 6.098.171
2017-11-27 2017-11-24 4 PEN Penumbra Inc
Common Stock
S - Sale X -278 61.173 -0,45 105,03 -29.198 6.425.000
2017-11-27 2017-11-24 4 PEN Penumbra Inc
Common Stock
S - Sale X -900 61.451 -1,44 104,42 -93.978 6.416.713
2017-11-27 2017-11-24 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.040 62.351 -1,64 103,51 -107.650 6.453.952
2017-11-27 2017-11-22 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 63.391 -0,16 107,20 -10.720 6.795.515
2017-11-27 2017-11-22 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.100 63.491 -1,70 106,53 -117.183 6.763.696
2017-11-27 2017-11-22 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.400 64.591 -2,12 105,47 -147.658 6.812.413
2017-11-22 2017-11-21 4 PEN Penumbra Inc
Common Stock
S - Sale X -5.000 65.991 -7,04 107,43 -537.150 7.089.413
2017-11-22 2017-11-21 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.300 70.991 -1,80 106,73 -138.749 7.576.869
2017-11-20 2017-11-20 4 PEN Penumbra Inc
Common Stock
S - Sale X -2.690 72.291 -3,59 106,56 -286.646 7.703.329
2017-11-20 2017-11-20 4 PEN Penumbra Inc
Common Stock
S - Sale X -7.400 74.981 -8,98 106,21 -785.954 7.963.732
2017-11-20 2017-11-20 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.200 82.381 -1,44 105,07 -126.084 8.655.772
2017-11-20 2017-11-17 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.100 83.581 -1,30 104,52 -114.972 8.735.886
2017-11-20 2017-11-17 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.200 84.681 -1,40 103,92 -124.704 8.800.050
2017-11-20 2017-11-17 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.990 85.881 -2,26 102,73 -204.433 8.822.555
2017-11-20 2017-11-16 4 PEN Penumbra Inc
Common Stock
S - Sale X -555 87.871 -0,63 105,44 -58.519 9.265.118
2017-11-20 2017-11-16 4 PEN Penumbra Inc
Common Stock
S - Sale X -5.821 88.426 -6,18 104,80 -610.041 9.267.045
2017-11-16 2017-11-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 94.247 -0,21 106,54 -21.308 10.041.075
2017-11-16 2017-11-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -277 94.447 -0,29 105,61 -29.254 9.974.548
2017-11-16 2017-11-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -4.823 94.724 -4,84 104,64 -504.679 9.911.919
2017-11-16 2017-11-14 4 PEN Penumbra Inc
Common Stock
S - Sale X -405 99.547 -0,41 108,28 -43.853 10.778.949
2017-11-16 2017-11-14 4 PEN Penumbra Inc
Common Stock
S - Sale X -3.195 99.952 -3,10 107,32 -342.887 10.726.849
2017-11-16 2017-11-14 4 PEN Penumbra Inc
Common Stock
S - Sale X -2.000 103.147 -1,90 106,09 -212.180 10.942.865
2017-05-01 2017-04-28 4 PEN Penumbra Inc
Common Stock
F - Taxes -82.029 407.578 -16,75 85,45 -7.009.378 34.827.540
2017-02-14 2017-02-13 4 PEN Penumbra Inc
Common Stock
S - Sale X -200 489.607 -0,04 74,30 -14.860 36.377.800
2017-02-14 2017-02-13 4 PEN Penumbra Inc
Common Stock
S - Sale X -600 489.807 -0,12 73,28 -43.968 35.893.057
2017-02-14 2017-02-13 4 PEN Penumbra Inc
Common Stock
S - Sale X -800 490.407 -0,16 72,35 -57.880 35.480.946
2017-02-10 2017-02-10 4 PEN Penumbra Inc
Common Stock
S - Sale X -4.043 491.207 -0,82 72,14 -291.662 35.435.673
2017-02-10 2017-02-10 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.357 495.250 -0,27 71,62 -97.188 35.469.805
2017-02-10 2017-02-09 4 PEN Penumbra Inc
Common Stock
S - Sale X -4.714 496.607 -0,94 72,14 -340.068 35.825.229
2017-02-10 2017-02-09 4 PEN Penumbra Inc
Common Stock
S - Sale X -985 501.321 -0,20 71,65 -70.575 35.919.650
2017-02-10 2017-02-09 4 PEN Penumbra Inc
Common Stock
S - Sale X -701 502.306 -0,14 70,23 -49.231 35.276.950
2017-02-10 2017-02-08 4 PEN Penumbra Inc
Common Stock
S - Sale X -3.700 503.007 -0,73 70,11 -259.407 35.265.821
2017-02-08 2017-02-06 4 PEN Penumbra Inc
Common Stock
S - Sale X -100 506.707 -0,02 70,00 -7.000 35.469.490
2017-02-03 2017-02-03 4 PEN Penumbra Inc
Common Stock
S - Sale X -3.699 506.807 -0,72 70,45 -260.595 35.704.553
2017-02-03 2017-02-02 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.812 510.506 -0,35 70,36 -127.492 35.919.202
2017-02-03 2017-02-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -400 512.318 -0,08 71,54 -28.616 36.651.230
2017-02-03 2017-02-01 4 PEN Penumbra Inc
Common Stock
S - Sale X -1.889 512.718 -0,37 70,75 -133.647 36.274.798
2016-11-17 2016-11-16 4 PEN Penumbra Inc
Common Stock
S - Sale X -22.100 514.607 -4,12 65,08 -1.438.268 33.490.624
2016-11-17 2016-11-15 4 PEN Penumbra Inc
Common Stock
S - Sale X -2.900 536.707 -0,54 65,01 -188.529 34.891.322
2015-09-17 3 PEN Penumbra Inc
Common Stock
1.079.214
2015-09-17 3 PEN Penumbra Inc
Common Stock
1.079.214
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)